Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
Main Authors: | Zhao, By Gan, Vasilakos, John P, Tross, Debra, Smirnov, Dmitri, Klinman, Dennis M |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075973/ |
Similar Items
-
CpG Oligonucleotides as Cancer Vaccine Adjuvants
by: Shirota, Hidekazu, et al.
Published: (2015) -
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
by: Smirnov, DV, et al.
Published: (2013) -
Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
by: Chatterjee, Piyali, et al.
Published: (2012) -
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
by: Kandimalla, Ekambar R., et al.
Published: (2013) -
Toll-Like Receptor 9 in Breast Cancer
by: Sandholm, Jouko, et al.
Published: (2014)